D optimal designs for three Poisson dose-response models.

about

A New Paradigm. "Learn - Learn More"; Dose-Exposure-Response at the Center of Drug Development and Regulatory Approval.

P2860

Q39248504-CA69A929-FE5F-4BC1-8894-4D1FDFC88BCA

P2860

D optimal designs for three Poisson dose-response models.

Item

http://www.wikidata.org/entity/Q43475482

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

D optimal designs for three Poisson dose-response models.

@en

D optimal designs for three Poisson dose-response models.

@nl

type

Item

label

D optimal designs for three Poisson dose-response models.

@en

D optimal designs for three Poisson dose-response models.

@nl

prefLabel

D optimal designs for three Poisson dose-response models.

@en

D optimal designs for three Poisson dose-response models.

@nl

P1476

D optimal designs for three Poisson dose-response models.

@en

P2093

Alan Maloney

http://www.w3.org/2001/XMLSchema#string

Marloes Schaddelee

http://www.w3.org/2001/XMLSchema#string

Ulrika S H Simonsson

http://www.w3.org/2001/XMLSchema#string

P2860

Performance in population models for count data, part I: maximum likelihood approximations.

Population Fisher information matrix and optimal design of discrete data responses in population pharmacodynamic experiments.

Learning versus confirming in clinical drug development.

Drug-drug interaction predictions with PBPK models and optimal multiresponse sampling time designs: application to midazolam and a phase I compound. Part 2: clinical trial results.

D-optimal designs for parameter estimation for indirect pharmacodynamic response models

Sample size/power calculations for population pharmacodynamic experiments involving repeated-count measurements.

Optimization of the intravenous glucose tolerance test in T2DM patients using optimal experimental design.

Optimisation of sampling windows design for population pharmacokinetic experiments.

An example of optimal phase II design for exposure response modelling.

Dose-response population analysis of levetiracetam add-on treatment in refractory epileptic patients with partial onset seizures.

P2888

s10928-013-9300-x

P304

201-211

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10928-013-9300-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23420229

http://www.w3.org/2001/XMLSchema#string

D optimal designs for three Poisson dose-response models.

about

P2860

P2860

D optimal designs for three Poisson dose-response models.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698